Biểu đồ giá cổ phiếu SGP
SGP Thu nhập
SpyGlass Pharma Inc
$0
0%
$0
Khi đóng cửa: Aug 24, 16:00:00 GMT-4
$0
0%
$0
Phiên sau giờ: Aug 24, 20:00:00 GMT-4
Quay lại
SpyGlass Pharma Inc (SGP) Thu nhập
Thống kê chính
Giá đóng cửa trước
--
Giá mở cửa
--
Phạm vi ngày
-
Phạm vi 52 tuần
-
Khối lượng
--
Khối lượng trung bình
--
Tỷ suất cổ tức
--
EPS (TTM)
--
Vốn hóa thị trường
--
SGP là gì?
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. The company is headquartered in Aliso Viejo, California and currently employs 65 full-time employees. The company went IPO on 2026-02-06. The firm is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.
